{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:44:32Z","timestamp":1761518672959,"version":"3.41.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1023\/a:1006142904301","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:53:09Z","timestamp":1040518389000},"page":"255-262","source":"Crossref","is-referenced-by-count":20,"title":["Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients"],"prefix":"10.1007","volume":"53","author":[{"given":"Ilan","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Perel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dov","family":"Flex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Figer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco M","family":"Altaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Bernheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drorn","family":"Yigael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Beyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"194285_CR1","first-page":"1","volume":"339","author":"Early Breast Cancer Trialists","year":"1992","unstructured":"Early Breast Cancer Trialists'Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1\u201315, 71\u201385, 1992","journal-title":"Lancet"},{"key":"194285_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(89)91741-8","volume":"1","author":"P Neven","year":"1989","unstructured":"Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E: Tamoxifen and the uterus and endometrium. Lancet 1: 375, 1989","journal-title":"Lancet"},{"key":"194285_CR3","first-page":"127","volume":"36","author":"X De Muylder","year":"1991","unstructured":"De Muylder X, Neven P, De Somer M: Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Oncol 36: 127\u2013129, 1991","journal-title":"Int J Gynecol Oncol"},{"key":"194285_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1471-0528.1993.tb15310.x","volume":"100","author":"I Cohen","year":"1993","unstructured":"Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras M, Beyth Y: Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynecol 100: 567\u2013570, 1993","journal-title":"Br J Obstet Gynecol"},{"key":"194285_CR5","first-page":"660","volume":"81","author":"E Lahti","year":"1993","unstructured":"Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Laatikainen T: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81: 660\u2013664, 1993","journal-title":"Obstet Gynecol"},{"key":"194285_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00682705","volume":"26","author":"B Uziely","year":"1993","unstructured":"Uziely B, Lewin A, Brufman G, Dorembus D, Mor-Yosef S: The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26: 101\u2013105, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"194285_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1994.1029","volume":"52","author":"I Cohen","year":"1994","unstructured":"Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras M, Beyth Y: Endometrial changes with tamoxifen: comparison between tamoxifen treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52: 185\u2013190, 1994","journal-title":"Gynecol Oncol"},{"key":"194285_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jcp.47.9.827","volume":"47","author":"SM Ismail","year":"1994","unstructured":"Ismail SM: Pathology of endometrium treated with tamoxifen. J Clin Pathol 47: 827\u2013833, 1994","journal-title":"J Clin Pathol"},{"key":"194285_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/gyno.1994.1263","volume":"55","author":"I Cohen","year":"1994","unstructured":"Cohen I, Tepper R, Rosen DJD, Shapira, J, Cordoba M, Dror Y, Altaras M, Beyth Y: Continous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 55: 138\u2013143, 1994","journal-title":"Gynecol Oncol"},{"key":"194285_CR10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","volume":"343","author":"RP Kedar","year":"1994","unstructured":"Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 343: 1318\u20131321, 1994","journal-title":"Lancet"},{"key":"194285_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00004347-199604000-00010","volume":"15","author":"I Cohen","year":"1996","unstructured":"Cohen I, Altaras MM, Shapira J, Tepper R, Rosen DJD, Cordoba M, Beyth Y: Time dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic, postmenopausal breast cancer patients. Int J Gynecol Pathol 15: 152\u2013157, 1996","journal-title":"Int J Gynecol Pathol"},{"key":"194285_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000291821","volume":"43","author":"I Cohen","year":"1997","unstructured":"Cohen I, Altaras MM, Shapira J, Tepper R, Cordoba M, Figer A, Zalel Y, Dror Y, Beyth Y: Different coexisting endometrial histological features in asymptomatic, postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 43: 60\u201363, 1997","journal-title":"Gynecol Obstet Invest"},{"key":"194285_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.1997.4739","volume":"66","author":"W-F Cheng","year":"1997","unstructured":"Cheng W-F, Lin H-H, Tong P-L, Huang S-C: Comparison of endometrial changes among symptomatic tamoxifentreated and non-treated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 66: 233\u2013237, 1997","journal-title":"Gynecol Oncol"},{"key":"194285_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004347-198906000-00005","volume":"8","author":"MA Nuovo","year":"1989","unstructured":"Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Barron B, Winkler B: Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8: 125\u2013131, 1989","journal-title":"Int J Gynecol Pathol"},{"key":"194285_CR15","first-page":"111","volume":"79","author":"D Corley","year":"1992","unstructured":"Corley D, Rome J, Curtis MT, Hogan WM, Noumoff JC, Livolsi VA: Postmenopausal bleeding from unusual polyps in women on tamoxifen therapy: Obstet Gynecol 79: 111\u2013116, 1992","journal-title":"Obstet Gynecol"},{"key":"194285_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bjc.1988.136","volume":"50","author":"G Ribeiro","year":"1988","unstructured":"Ribeiro G, Swindell R: The Christie Hospital adjuvant tamoxifen trial\u2013status at 10 years. Br J Cancer 50: 601\u2013603, 1988","journal-title":"Br J Cancer"},{"key":"194285_CR17","first-page":"375","volume":"1","author":"H Stewart","year":"1989","unstructured":"Stewart H, Knight GM: Tamoxifen and the uterus and endometrium. Lancet 1: 375\u2013376, 1989","journal-title":"Lancet"},{"key":"194285_CR18","first-page":"563","volume":"3","author":"L Hardell","year":"1989","unstructured":"Hardell L: Tamoxifen as a risk factor for carcinoma of corpus uteri. Lancet 3: 563, 1989","journal-title":"Lancet"},{"key":"194285_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"1","author":"T Fornander","year":"1989","unstructured":"Fornander T, Cedermark B, Mattsson W, Skoog L, Theve T, Askergen J, Rutquist LE, Glas Y, Silfversward CM, Somel A, Wilkins N, Hjalmar ML: Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1: 117\u2013120, 1989","journal-title":"Lancet"},{"key":"194285_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnci\/83.14.1013","volume":"83","author":"M Andersson","year":"1991","unstructured":"Andersson M, Storm HH, Mouridsen HT: Incidence of new primary cancer after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013\u20131017, 1991","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR21","first-page":"416","volume":"59","author":"RA Segna","year":"1992","unstructured":"Segna RA, Dottino PR, Delglish L, Cohen CJ: Tamoxifen and endometrial cancer. Mt Sinai J Med 59: 416\u2013418, 1992","journal-title":"Mt Sinai J Med"},{"key":"194285_CR22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","volume":"11","author":"U Magriples","year":"1993","unstructured":"Magriples U, Naftolin F, Schwartz PE, Carcangiu MI: High grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11: 485\u2013490, 1993","journal-title":"J Clin Oncol"},{"key":"194285_CR23","first-page":"165","volume":"82","author":"MAF Seoud","year":"1993","unstructured":"Seoud MAF, Johnson J, Weed JC: Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82: 165\u2013169, 1993","journal-title":"Obstet Gynecol"},{"key":"194285_CR24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jnci\/85.22.1850","volume":"85","author":"T Fornander","year":"1993","unstructured":"Fornander T, Hellstrom AC, Moberger B: Descriptive clinicopathologic study of 17 patietns with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 85: 1850\u20131855, 1993","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher B, Costantino J, Redmond C, Fisher ER, Wickerham L, Cronin WM: Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86: 527\u2013537, 1994","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","volume":"343","author":"FE Van Leeuwen","year":"1994","unstructured":"Van Leeuwen FE, Benraadt J, Coebergh JWW, Kiemeney LA, Gimbrere CH, Otter R: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343: 448\u2013452, 1994","journal-title":"Lancet"},{"key":"194285_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/gyno.1994.1271","volume":"55","author":"RF Barakat","year":"1994","unstructured":"Barakat RF, Wang G, Curtin J, Hoskins WJ: Tamoxifen use in breast cancer patients who subsequently develop corpus uterus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 55: 164\u2013168, 1994","journal-title":"Gynecol Oncol"},{"key":"194285_CR28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jnci\/87.9.645","volume":"87","author":"LE Rutquist","year":"1995","unstructured":"Rutquist LE, Johansson H, Signomklao T, Johnson U, Fornander T, Wilking N: Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancy. J Natl Cancer Inst 87: 645\u2013651, 1995","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jnci\/87.18.1359","volume":"87","author":"LS Cook","year":"1995","unstructured":"Cook LS, Weiss NS, Schwartz SM, White E, McNight B, Moore DE, Daling JR: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancers. J Natl Cancer Inst 87: 1359\u20131364, 1995","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/gyno.1995.0005","volume":"59","author":"DC Robinson","year":"1995","unstructured":"Robinson DC, Bloss JD, Schiano MA: A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Gynecol Oncol 59: 186\u2013190, 1995","journal-title":"Gynecol Oncol"},{"key":"194285_CR31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/jnci\/88.12.832","volume":"88","author":"RE Curtis","year":"1996","unstructured":"Curtis RE, Boice JD Jr, Shiner DA, Hankey BF, Fraumeni JF Jr: Second cancers after adjuvant tamoxifen therapy. J Natl Cancer Inst 88: 832\u2013834, 1996","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl","key":"194285_CR32","first-page":"140","volume":"24","author":"WT Creasman","year":"1997","unstructured":"Creasman WT: Endometrial cancer: incidence, prognostic factors, diagnosis and treatment. Semin Oncol 24 (Suppl): 140\u2013150, 1997","journal-title":"Semin Oncol"},{"key":"194285_CR33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1989.7.10.1474","volume":"7","author":"LE Rutquist","year":"1989","unstructured":"Rutquist LE, Cedermark B, Fornander T: The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol 7: 1474\u20131484, 1989","journal-title":"J Clin Oncol"},{"key":"194285_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-4731(88)90113-6","volume":"30","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Robinson SP, Jordan VC: Estradiol stimulation of growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen. J Steroid Biochem 30: 311\u2013314, 1988","journal-title":"J Steroid Biochem"},{"key":"194285_CR35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/83.7.492","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, Lababidi MK, Langan-Fahey S: Suppression of mouse mammary tumorigenesis by long-acting tamoxifen therapy. J Natl Cancer Inst 83: 492\u2013496, 1991","journal-title":"J Natl Cancer Inst"},{"key":"194285_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001703-199802000-00003","volume":"10","author":"P Neven","year":"1998","unstructured":"Neven P, Vergote I: Controversies regarding tamoxifen and uterine carcinoma. Current Opinion in Obstet Gynecol 10: 9\u201314, 1998","journal-title":"Current Opinion in Obstet Gynecol"},{"issue":"Suppl","key":"194285_CR37","first-page":"261","volume":"32","author":"VC Jordan","year":"1984","unstructured":"Jordan VC: Laboratory evidence to support the use of longacting tamoxifen therapy for breast cancer. Horm Res 32 (Suppl): 261\u2013265, 1984","journal-title":"Horm Res"},{"key":"194285_CR38","first-page":"331","volume-title":"Adjuvant Therapy for Cancer","author":"A Wallgran","year":"1984","unstructured":"Wallgran A, Barae E, Carstensen J, et al.: Should adjuvant tamoxifen be given for several years in breast cancer? In: Jones SE, Salman SE (eds) Adjuvant Therapy for Cancer. IV. Grune & Stratton, New York, 1984, pp 331\u2013337"},{"key":"194285_CR39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0090-8258(92)90273-L","volume":"45","author":"DM Wolf","year":"1992","unstructured":"Wolf DM, Jordan VC: Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecol Oncol 45: 118\u2013128, 1992","journal-title":"Gynecol Oncol"},{"key":"194285_CR40","first-page":"467","volume":"1","author":"VC Jordan","year":"1995","unstructured":"Jordan VC, Assikis VJ: Endometrial carcinoma and tamoxifen: clearing up a controversy. Clin Cancer Res 1: 467\u2013472, 1995","journal-title":"Clin Cancer Res"},{"key":"194285_CR41","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1698::AID-CNCR16>3.0.CO;2-#","volume":"82","author":"K Katase","year":"1998","unstructured":"Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F: The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Cancer 82: 1698\u20131703, 1998","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006142904301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006142904301\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006142904301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006142904301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:27:24Z","timestamp":1750480044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006142904301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["194285"],"URL":"https:\/\/doi.org\/10.1023\/a:1006142904301","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}